$MBBC
Marathon Bancorp, Inc. /MD/

2021 Q2 Form 10-K Financial Statement

#000155837021012801 Filed on September 28, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2021 2020 Q2
Revenue $6.484M
YoY Change 9.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $207.4K
YoY Change 18.29%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $1.091M
YoY Change -19.57%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $1.851M
YoY Change 266.14%
Income Tax $477.7K
% Of Pretax Income 25.81%
Net Earnings $1.373M
YoY Change 228.59%
Net Earnings / Revenue 21.18%
Basic Earnings Per Share $0.64
Diluted Earnings Per Share $0.64
COMMON SHARES
Basic Shares Outstanding 2.229M 2.142M
Diluted Shares Outstanding 2.142M

Balance Sheet

Concept 2021 Q2 2021 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $46.05M $24.27M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.850M $1.850M $1.969M
YoY Change -6.04%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $269.7K
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $213.6M $213.6M $170.7M
YoY Change 25.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $10.37M $6.375M
YoY Change 62.7%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $10.37M
YoY Change
Other Long-Term Liabilities $1.450M
YoY Change
Total Long-Term Liabilities $11.82M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities $11.82M
Total Liabilities $183.8M $183.8M $149.9M
YoY Change 22.63%
SHAREHOLDERS EQUITY
Retained Earnings $22.09M $20.72M
YoY Change 6.63%
Common Stock $8.506M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $29.85M $29.85M $20.78M
YoY Change
Total Liabilities & Shareholders Equity $213.6M $213.6M $170.7M
YoY Change 25.18%

Cashflow Statement

Concept 2021 Q2 2021 2020 Q2
OPERATING ACTIVITIES
Net Income $1.373M
YoY Change 228.59%
Depreciation, Depletion And Amortization $207.4K
YoY Change 18.29%
Cash From Operating Activities $1.461M
YoY Change 37.28%
INVESTING ACTIVITIES
Capital Expenditures $88.47K
YoY Change -69.73%
Acquisitions
YoY Change
Other Investing Activities -$20.74M
YoY Change
Cash From Investing Activities -$21.26M
YoY Change -710.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 41.57M
YoY Change 142.81%
NET CHANGE
Cash From Operating Activities 1.461M
Cash From Investing Activities -21.26M
Cash From Financing Activities 41.57M
Net Change In Cash 21.77M
YoY Change 0.5%
FREE CASH FLOW
Cash From Operating Activities $1.461M
Capital Expenditures $88.47K
Free Cash Flow $1.373M
YoY Change 77.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 mara Debit Card Expenses
DebitCardExpenses
89347
CY2020 mara Debit Card Expenses
DebitCardExpenses
80382
CY2021 dei Security Exchange Name
SecurityExchangeName
NONE
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001835385
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2229497
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2229497
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2229497
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2229497
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
000-56269
CY2021 dei Entity Registrant Name
EntityRegistrantName
MARATHON BANCORP, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2191258
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
500 Scott Street
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Wausau
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
WI
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
54403
CY2021 dei City Area Code
CityAreaCode
715
CY2021 dei Local Phone Number
LocalPhoneNumber
845-7331
CY2021 dei Security12b Title
Security12bTitle
None
CY2021 dei Trading Symbol
TradingSymbol
None
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Public Float
EntityPublicFloat
0
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2229497
CY2021Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
1989643
CY2020Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
3610747
CY2021Q2 us-gaap Federal Funds Sold
FederalFundsSold
44059000
CY2020Q2 us-gaap Federal Funds Sold
FederalFundsSold
20664000
CY2021Q2 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
46048643
CY2020Q2 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
24274747
CY2021Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
2062463
CY2020Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
1944550
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10909764
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
15008087
CY2021Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
770438
CY2020Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3158960
CY2021Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
708949
CY2020Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
2841353
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2186182
CY2020Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
1699977
CY2021Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
144169318
CY2020Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
116918893
CY2021Q2 us-gaap Interest Receivable
InterestReceivable
552516
CY2020Q2 us-gaap Interest Receivable
InterestReceivable
499740
CY2020Q2 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
64080
CY2021Q2 us-gaap Investment Owned Restricted Cost
InvestmentOwnedRestrictedCost
262200
CY2020Q2 us-gaap Investment Owned Restricted Cost
InvestmentOwnedRestrictedCost
262200
CY2021Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
5968734
CY2020Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
5804067
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1849917
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1968797
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
269715
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
700380
CY2021Q2 us-gaap Other Assets
OtherAssets
825081
CY2020Q2 us-gaap Other Assets
OtherAssets
363355
CY2021Q2 us-gaap Assets
Assets
213627300
CY2020Q2 us-gaap Assets
Assets
170650249
CY2021Q2 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
23633008
CY2020Q2 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
12382548
CY2021Q2 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
148323109
CY2020Q2 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
121632371
CY2020Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
8000000
CY2021Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
10372148
CY2020Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
6374898
CY2021Q2 us-gaap Other Liabilities
OtherLiabilities
1449884
CY2020Q2 us-gaap Other Liabilities
OtherLiabilities
1478097
CY2021Q2 us-gaap Liabilities
Liabilities
183778149
CY2020Q2 us-gaap Liabilities
Liabilities
149867914
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
22295
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8484019
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
22088669
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
78400
CY2020 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
67800
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
361808
CY2020 us-gaap Other Noninterest Expense
OtherNoninterestExpense
304118
CY2021 us-gaap Noninterest Expense
NoninterestExpense
5437809
CY2020 us-gaap Noninterest Expense
NoninterestExpense
4902498
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1850779
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2142474
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
505479
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
477720
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
87610
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1373059
CY2020 us-gaap Net Income Loss
NetIncomeLoss
417869
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.64
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
20715610
CY2021Q2 us-gaap Unearned Esop Shares
UnearnedESOPShares
866499
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
120667
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
66725
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
29849151
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
20782335
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
213627300
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
170650249
CY2021 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
6090126
CY2020 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
5282516
CY2021 us-gaap Interest Income Debt Securities Available For Sale Operating
InterestIncomeDebtSecuritiesAvailableForSaleOperating
361565
CY2020 us-gaap Interest Income Debt Securities Available For Sale Operating
InterestIncomeDebtSecuritiesAvailableForSaleOperating
533480
CY2021 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
32463
CY2020 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
92587
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
6484154
CY2020 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
5908583
CY2021 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1049621
CY2020 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1334832
CY2021 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
41606
CY2020 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
21891
CY2021 us-gaap Interest Expense
InterestExpense
1091227
CY2020 us-gaap Interest Expense
InterestExpense
1356723
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5392927
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4551860
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
150000
CY2021 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
5392927
CY2020 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
4401860
CY2021 mara Service Charges On Deposit Accounts
ServiceChargesOnDepositAccounts
168016
CY2020 mara Service Charges On Deposit Accounts
ServiceChargesOnDepositAccounts
177768
CY2021 mara Mortgage Banking Income
MortgageBankingIncome
1527087
CY2020 mara Mortgage Banking Income
MortgageBankingIncome
605973
CY2021 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
164667
CY2020 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
163797
CY2021 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
10840
CY2020 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-2708
CY2021 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
25051
CY2020 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
61287
CY2021 us-gaap Noninterest Income
NoninterestIncome
1895661
CY2020 us-gaap Noninterest Income
NoninterestIncome
1006117
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3345057
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3021626
CY2021 us-gaap Occupancy Net
OccupancyNet
670954
CY2020 us-gaap Occupancy Net
OccupancyNet
673773
CY2021 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
463131
CY2020 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
416288
CY2021 us-gaap Professional Fees
ProfessionalFees
366526
CY2020 us-gaap Professional Fees
ProfessionalFees
274161
CY2021 us-gaap Marketing Expense
MarketingExpense
62586
CY2020 us-gaap Marketing Expense
MarketingExpense
64350
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1373059
CY2020 us-gaap Net Income Loss
NetIncomeLoss
417869
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-100981
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
273277
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-26851
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
76951
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-74130
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
196326
CY2021 us-gaap Oci Debt Securities Available For Sale Transfer To Held To Maturity Adjustment From Aoci For Amortization Of Gain Loss After Tax
OciDebtSecuritiesAvailableForSaleTransferToHeldToMaturityAdjustmentFromAociForAmortizationOfGainLossAfterTax
-128072
CY2020 us-gaap Oci Debt Securities Available For Sale Transfer To Held To Maturity Adjustment From Aoci For Amortization Of Gain Loss After Tax
OciDebtSecuritiesAvailableForSaleTransferToHeldToMaturityAdjustmentFromAociForAmortizationOfGainLossAfterTax
-28353
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
53942
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
224679
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1427001
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
642548
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
20139787
CY2020 us-gaap Net Income Loss
NetIncomeLoss
417869
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
224679
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
20782335
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1400000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8505977
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1373059
CY2021 mara Purchase Of Employee Stock Ownership Plan Shares
PurchaseOfEmployeeStockOwnershipPlanShares
87397
CY2021 mara Purchase Of Employee Stock Ownership Plan Shares Value
PurchaseOfEmployeeStockOwnershipPlanSharesValue
873970
CY2021 mara Employee Stock Ownership Plan Esop Amount Of Committed To Be Released Shares
EmployeeStockOwnershipPlanEsopAmountOfCommittedToBeReleasedShares
7808
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
53942
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
29849151
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1373059
CY2020 us-gaap Net Income Loss
NetIncomeLoss
417869
CY2021 us-gaap Depreciation
Depreciation
207351
CY2020 us-gaap Depreciation
Depreciation
175295
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
150000
CY2021 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
7808
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-132600
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-95413
CY2021 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
1046851
CY2020 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
488296
CY2021 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
10840
CY2020 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-2708
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
458420
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
93601
CY2021 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
164667
CY2020 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
163797
CY2021 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
52776
CY2020 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-48130
CY2021 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
50642912
CY2020 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
26527998
CY2021 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
51689763
CY2020 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
27016294
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
461726
CY2021 us-gaap Payments For Federal Home Loan Bank Advances
PaymentsForFederalHomeLoanBankAdvances
8000000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
32465
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-28213
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
277527
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1461016
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1064281
CY2021 mara Net Change Interest Bearing Deposits In Other Financial Institutions
NetChangeInterestBearingDepositsInOtherFinancialInstitutions
117913
CY2020 mara Net Change Interest Bearing Deposits In Other Financial Institutions
NetChangeInterestBearingDepositsInOtherFinancialInstitutions
803863
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1112500
CY2020 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
3219305
CY2021 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
4979796
CY2020 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
9105361
CY2021 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
2257018
CY2020 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
153737
CY2020 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
-2700
CY2021 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
27250425
CY2020 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
1524181
CY2021 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
74920
CY2020 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
58960
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88471
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
292253
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21257575
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3481156
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
8505977
CY2021 mara Payments To Acquire Employee Stock Ownership Plan Esop Shares
PaymentsToAcquireEmployeeStockOwnershipPlanEsopShares
873970
CY2021 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
37941198
CY2020 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
2745439
CY2020 us-gaap Proceeds From Federal Home Loan Bank Advances
ProceedsFromFederalHomeLoanBankAdvances
8000000
CY2021 mara Borrowings Repayments Of Ppplf Funding Net
BorrowingsRepaymentsOfPpplfFundingNet
3997250
CY2020 mara Borrowings Repayments Of Ppplf Funding Net
BorrowingsRepaymentsOfPpplfFundingNet
6374898
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41570455
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17120337
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21773896
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21665774
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24274747
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2608973
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46048643
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24274747
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1073861
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1360048
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10000
CY2020 mara Transfer Of Loans To Foreclosed Assets
TransferOfLoansToForeclosedAssets
125748
CY2021Q2 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
1226223
CY2021 us-gaap Sale Of Stock Percentage Of Ownership Before Transaction
SaleOfStockPercentageOfOwnershipBeforeTransaction
0.550
CY2021 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1003274
CY2021Q2 us-gaap Share Price
SharePrice
10.00
CY2021 us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
0.450
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
10000000.0
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1400000
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
8500000
CY2021 mara Payments To Acquire Employee Stock Ownership Plan Esop Shares
PaymentsToAcquireEmployeeStockOwnershipPlanEsopShares
874000
CY2021 mara Number Of Business Facilities
NumberOfBusinessFacilities
4
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant changes in the near term relate to the determination of the allowance for loan losses, valuation of deferred tax assets, other-than-temporary impairment of debt securities and fair value of financial assets and liabilities.</span></p>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The majority of the Company’s loans and commitments to extend credit have been granted to customers in the Company’s market area. Although the Company’s loan portfolio is diversified, a substantial portion of the Company’s customers’ ability to honor their contracts is dependent upon the local business economy in which the Company operates. The concentration of credit by type of loan is set forth in Note 4.</p>
CY2021Q2 us-gaap Investment Owned Restricted Cost
InvestmentOwnedRestrictedCost
262200
CY2020Q2 us-gaap Investment Owned Restricted Cost
InvestmentOwnedRestrictedCost
262200
CY2021Q2 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
131000
CY2020Q2 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
238000
CY2021Q2 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
0
CY2020Q2 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
164052
CY2020Q2 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
64080
CY2021Q2 us-gaap Foreclosed Assets
ForeclosedAssets
0
CY2021Q2 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Asset
FairValueDisclosureOffbalanceSheetRisksFaceAmountAsset
80628000
CY2020Q2 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Asset
FairValueDisclosureOffbalanceSheetRisksFaceAmountAsset
48250000
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 us-gaap Advertising Expense
AdvertisingExpense
62586
CY2020 us-gaap Advertising Expense
AdvertisingExpense
64350
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
1373059
CY2020 us-gaap Net Income Loss
NetIncomeLoss
417869
CY2021 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2229497
CY2021 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
87023
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2142474
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassifications</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Certain reclassifications of amounts previously reported have been made to the accompanying consolidated financial statements to maintain consistency between periods presented. The reclassification had no impact on net income or equity.</p>
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10909764
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
15008087
CY2021Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
708949
CY2020Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
2841353
CY2021Q2 us-gaap Debt Securities Available For Sale And Held To Maturity
DebtSecuritiesAvailableForSaleAndHeldToMaturity
11618713
CY2020Q2 us-gaap Debt Securities Available For Sale And Held To Maturity
DebtSecuritiesAvailableForSaleAndHeldToMaturity
17849440
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
10649706
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
305630
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
45572
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10909764
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
14647048
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
383250
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
22211
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
15008087
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
33460
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1261843
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
12112
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
250438
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
45572
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1512281
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1582
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
131420
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
20629
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
692606
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
22211
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
824026
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
4
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
5
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
6
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
7
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
946083
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
966300
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
4561900
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
4630702
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
584258
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
601194
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
6092241
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
6198196
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
10649706
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10909764
CY2021Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
708949
CY2021Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
770438
CY2021Q2 us-gaap Debt Securities Available For Sale Restricted
DebtSecuritiesAvailableForSaleRestricted
1118000
CY2020Q2 us-gaap Debt Securities Available For Sale Restricted
DebtSecuritiesAvailableForSaleRestricted
1689000
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2021Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
146873595
CY2020Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
118873357
CY2021Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
518095
CY2020Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
254487
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2186182
CY2020Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
1699977
CY2021Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
144169318
CY2020Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
116918893
CY2020Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
1699977
CY2021 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
486205
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2186182
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
2186182
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2186182
CY2021Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
539423
CY2021Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
146334172
CY2021Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
146873595
CY2019Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
1628960
CY2020 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-88920
CY2020 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
9937
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
150000
CY2020Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
1699977
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
1055383
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
644594
CY2020Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
1699977
CY2020Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
5175527
CY2020Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
113697830
CY2020Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
118873357
CY2021Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
178394
CY2020Q2 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
255067
CY2021Q2 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
539423
CY2021Q2 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
597069
CY2021 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
563291
CY2021 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
35391
CY2020Q2 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
2598904
CY2020Q2 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
2656550
CY2020 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
2656312
CY2020 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
128119
CY2020Q2 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
2576623
CY2020Q2 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
2591937
CY2020Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
1055383
CY2020 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
2688889
CY2020 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
139399
CY2020 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2021 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2021Q2 mara Financing Receivables Commitments To Lend Additional Funds On Restructured Loans
FinancingReceivablesCommitmentsToLendAdditionalFundsOnRestructuredLoans
0
CY2021 mara Financing Receivables Threshold Loan Modification Period Due To Covid19
FinancingReceivablesThresholdLoanModificationPeriodDueToCovid19
P3M
CY2021 mara Financing Receivables Loan Modification Potential Extension Period Maximum
FinancingReceivablesLoanModificationPotentialExtensionPeriodMaximum
P6M
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4547050
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4462829
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2697133
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2494032
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1849917
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1968797
CY2021 us-gaap Depreciation
Depreciation
207351
CY2021Q2 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
70596
CY2020 us-gaap Depreciation
Depreciation
175295
CY2021Q2 mara Operating Lease Number Of Branch Locations Leased
OperatingLeaseNumberOfBranchLocationsLeased
2
CY2020Q2 us-gaap Financial Instruments Owned And Pledged As Collateral Amount Eligible To Be Repledged By Counterparty
FinancialInstrumentsOwnedAndPledgedAsCollateralAmountEligibleToBeRepledgedByCounterparty
31283165
CY2020Q2 us-gaap Pledged Financial Instruments Not Separately Reported Securities For Federal Home Loan Bank
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForFederalHomeLoanBank
262200
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
99092
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
90560
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
18000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
207652
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
100564
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
105245
CY2020Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
12200000
CY2021Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
12200000
CY2021Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
5968734
CY2020Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
5804067
CY2021Q2 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
21223510
CY2021Q2 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
16020922
CY2021Q2 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
8387838
CY2021Q2 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
6344230
CY2021Q2 us-gaap Time Deposit Maturities Year Five
TimeDepositMaturitiesYearFive
4689026
CY2021Q2 us-gaap Time Deposit Maturities After Year Five
TimeDepositMaturitiesAfterYearFive
2568803
CY2021Q2 us-gaap Time Deposits
TimeDeposits
59234329
CY2021Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
4605654
CY2020Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
4209202
CY2021Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
0
CY2020Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
8000000
CY2021Q2 us-gaap Financial Instruments Owned And Pledged As Collateral Amount Eligible To Be Repledged By Counterparty
FinancialInstrumentsOwnedAndPledgedAsCollateralAmountEligibleToBeRepledgedByCounterparty
35421507
CY2021Q2 us-gaap Pledged Financial Instruments Not Separately Reported Securities For Federal Home Loan Bank
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForFederalHomeLoanBank
262200
CY2020 us-gaap Federal Home Loan Bank Advances Activity For Year Average Balance Of Agreements Outstanding
FederalHomeLoanBankAdvancesActivityForYearAverageBalanceOfAgreementsOutstanding
8000000
CY2021Q2 us-gaap Federal Home Loan Bank Advances Activity For Year Maximum Outstanding At Any Month End
FederalHomeLoanBankAdvancesActivityForYearMaximumOutstandingAtAnyMonthEnd
8000000
CY2020Q2 us-gaap Federal Home Loan Bank Advances Activity For Year Maximum Outstanding At Any Month End
FederalHomeLoanBankAdvancesActivityForYearMaximumOutstandingAtAnyMonthEnd
8000000
CY2020Q2 us-gaap Federal Home Loan Bank Advances Activity For Year Average Interest Rate At Period End
FederalHomeLoanBankAdvancesActivityForYearAverageInterestRateAtPeriodEnd
0.00325
CY2021 us-gaap Federal Home Loan Bank Advances Activity For Year Average Interest Rate For Year
FederalHomeLoanBankAdvancesActivityForYearAverageInterestRateForYear
0.0029
CY2020 us-gaap Federal Home Loan Bank Advances Activity For Year Average Interest Rate For Year
FederalHomeLoanBankAdvancesActivityForYearAverageInterestRateForYear
0.0095
CY2020Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
0
CY2021Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
0
CY2021Q2 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
514353
CY2020Q2 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
282000
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
432127
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
799645
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
131723
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
69325
CY2021Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
43003
CY2020Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
82783
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
606853
CY2020Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
951753
CY2021Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
80471
CY2020Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
58256
CY2021Q2 mara Deferred Tax Liabilities Allowance For Loan Losses
DeferredTaxLiabilitiesAllowanceForLoanLosses
21882
CY2020Q2 mara Deferred Tax Liabilities Allowance For Loan Losses
DeferredTaxLiabilitiesAllowanceForLoanLosses
21882
CY2021Q2 us-gaap Deferred Tax Liabilities Mortgage Servicing Rights
DeferredTaxLiabilitiesMortgageServicingRights
163942
CY2020Q2 us-gaap Deferred Tax Liabilities Mortgage Servicing Rights
DeferredTaxLiabilitiesMortgageServicingRights
72635
CY2020Q2 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
98351
CY2021Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
247
CY2020Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
249
CY2021Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
337138
CY2020Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
251373
CY2021Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
269715
CY2020Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
700380
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
19300
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-5991
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
458420
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
93601
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
477720
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
87610
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
388665
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
106151
CY2021 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
13936
CY2020 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
19479
CY2021 mara Effective Income Tax Rate Reconciliation Earnings On Bank Owned Life Insurance Amount
EffectiveIncomeTaxRateReconciliationEarningsOnBankOwnedLifeInsuranceAmount
34580
CY2020 mara Effective Income Tax Rate Reconciliation Earnings On Bank Owned Life Insurance Amount
EffectiveIncomeTaxRateReconciliationEarningsOnBankOwnedLifeInsuranceAmount
34397
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
106736
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
19954
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
30835
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
15381
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
477720
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
87610
CY2021 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.15
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
75000
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
69746
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
873970
CY2021 us-gaap Stock Issued During Period Shares Employee Stock Ownership Plan
StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
87397
CY2021 us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
10.00
CY2021Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0325
CY2021 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
7808
CY2021Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
747
CY2021Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares
EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares
86650
CY2021Q2 mara Employee Stock Ownership Plan Esop Value Of Shares Committed To Be Released
EmployeeStockOwnershipPlanEsopValueOfSharesCommittedToBeReleased
911558
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
CY2021 mara Employee Medical Benefit Plan Maximum Claims Per Employee
EmployeeMedicalBenefitPlanMaximumClaimsPerEmployee
30000
CY2021 mara Employee Medical Benefit Plan Aggregate Stop Loss
EmployeeMedicalBenefitPlanAggregateStopLoss
1000000
CY2021 us-gaap Health Care Organization Health Care Costs Gross
HealthCareOrganizationHealthCareCostsGross
568947
CY2020 us-gaap Health Care Organization Health Care Costs Gross
HealthCareOrganizationHealthCareCostsGross
627934
CY2020Q2 mara Employee Medical Benefit Plan Liability
EmployeeMedicalBenefitPlanLiability
118481
CY2021Q2 mara Employee Medical Benefit Plan Liability
EmployeeMedicalBenefitPlanLiability
37735
CY2021Q2 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
25452000
CY2021Q2 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
12.47
CY2021Q2 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
15313000
CY2021Q2 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
7.5
CY2021Q2 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
17355000
CY2021Q2 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
8.5
CY2020Q2 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
20015000
CY2020Q2 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
13.58
CY2020Q2 us-gaap Common Equity Tier One Capital Required For Capital Adequacy
CommonEquityTierOneCapitalRequiredForCapitalAdequacy
6632000
CY2020Q2 us-gaap Banking Regulation Common Equity Tier One Risk Based Capital Ratio Capital Adequacy Minimum
BankingRegulationCommonEquityTierOneRiskBasedCapitalRatioCapitalAdequacyMinimum
4.5
CY2020Q2 us-gaap Common Equity Tier One Capital Required To Be Well Capitalized
CommonEquityTierOneCapitalRequiredToBeWellCapitalized
9580000
CY2020Q2 us-gaap Banking Regulation Common Equity Tier One Risk Based Capital Ratio Well Capitalized Minimum
BankingRegulationCommonEquityTierOneRiskBasedCapitalRatioWellCapitalizedMinimum
6.5
CY2020Q2 mara Excess Common Equity Tier One Capital
ExcessCommonEquityTierOneCapital
10314000
CY2020Q2 mara Excess Common Equity Tier One Capital Ratio
ExcessCommonEquityTierOneCapitalRatio
7.0
CY2020Q2 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
20015000
CY2020Q2 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
13.58
CY2020Q2 us-gaap Tier One Risk Based Capital Required For Capital Adequacy
TierOneRiskBasedCapitalRequiredForCapitalAdequacy
8843000
CY2020Q2 us-gaap Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
6.0
CY2020Q2 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
11791000
CY2020Q2 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
8.0
CY2020Q2 us-gaap Excess Tier One Risk Based Capital
ExcessTierOneRiskBasedCapital
12524000
CY2020Q2 us-gaap Excess Tier One Risk Based Capital To Risk Weighted Assets
ExcessTierOneRiskBasedCapitalToRiskWeightedAssets
8.5
CY2020Q2 us-gaap Capital
Capital
21715000
CY2020Q2 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
14.74
CY2020Q2 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
11786000
CY2020Q2 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
8.0
CY2020Q2 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
14732000
CY2020Q2 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
10.0
CY2020Q2 us-gaap Excess Capital
ExcessCapital
15471000
CY2020Q2 us-gaap Excess Capital To Risk Weighted Assets
ExcessCapitalToRiskWeightedAssets
10.5
CY2020Q2 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
20015000
CY2020Q2 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
13.12
CY2020Q2 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
6102000
CY2020Q2 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
4.0
CY2020Q2 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
7628000
CY2020Q2 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
5.0
CY2020Q2 us-gaap Excess Tier One Leverage Capital
ExcessTierOneLeverageCapital
7628000
CY2020Q2 us-gaap Excess Tier One Leverage Capital To Average Assets
ExcessTierOneLeverageCapitalToAverageAssets
5.0
CY2021Q2 mara Net Worth Of Entity
NetWorthOfEntity
25842077
CY2021Q2 mara General Loan Loss Reserve
GeneralLoanLossReserve
2186182
CY2021Q2 mara Net Worth Of Entity Percent Of Total Assets
NetWorthOfEntityPercentOfTotalAssets
0.1312
CY2020Q2 mara Net Worth Of Entity
NetWorthOfEntity
20782335
CY2020Q2 mara General Loan Loss Reserve
GeneralLoanLossReserve
644594
CY2020Q2 mara Net Worth Of Entity Percent Of Total Assets
NetWorthOfEntityPercentOfTotalAssets
0.1256
CY2021Q2 mara Commitments To Grant Loans Percentage Outstanding With Fixed Interest Rate
CommitmentsToGrantLoansPercentageOutstandingWithFixedInterestRate
0.72
CY2021Q2 mara Commitments To Grant Loans Percentage Outstanding With Variable Interest Rate
CommitmentsToGrantLoansPercentageOutstandingWithVariableInterestRate
0.28
CY2020Q2 mara Commitments To Grant Loans Percentage Outstanding With Fixed Interest Rate
CommitmentsToGrantLoansPercentageOutstandingWithFixedInterestRate
0.67
CY2020Q2 mara Commitments To Grant Loans Percentage Outstanding With Variable Interest Rate
CommitmentsToGrantLoansPercentageOutstandingWithVariableInterestRate
0.33

Files In Submission

Name View Source Status
0001558370-21-012801-index-headers.html Edgar Link pending
0001558370-21-012801-index.html Edgar Link pending
0001558370-21-012801.txt Edgar Link pending
0001558370-21-012801-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mara-20210630.xsd Edgar Link pending
mara-20210630x10k.htm Edgar Link pending
mara-20210630x10k_htm.xml Edgar Link completed
mara-20210630xex21.htm Edgar Link pending
mara-20210630xex23.htm Edgar Link pending
mara-20210630xex31d1.htm Edgar Link pending
mara-20210630xex31d2.htm Edgar Link pending
mara-20210630xex32d1.htm Edgar Link pending
mara-20210630xex32d2.htm Edgar Link pending
mara-20210630xex4d2.htm Edgar Link pending
mara-20210630_cal.xml Edgar Link unprocessable
mara-20210630_def.xml Edgar Link unprocessable
mara-20210630_lab.xml Edgar Link unprocessable
mara-20210630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending